These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 29070699)

  • 1. Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients.
    Michelakis ED; Gurtu V; Webster L; Barnes G; Watson G; Howard L; Cupitt J; Paterson I; Thompson RB; Chow K; O'Regan DP; Zhao L; Wharton J; Kiely DG; Kinnaird A; Boukouris AE; White C; Nagendran J; Freed DH; Wort SJ; Gibbs JSR; Wilkins MR
    Sci Transl Med; 2017 Oct; 9(413):. PubMed ID: 29070699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate.
    Piao L; Sidhu VK; Fang YH; Ryan JJ; Parikh KS; Hong Z; Toth PT; Morrow E; Kutty S; Lopaschuk GD; Archer SL
    J Mol Med (Berl); 2013 Mar; 91(3):333-46. PubMed ID: 23247844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
    Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
    Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.
    Piao L; Fang YH; Cadete VJ; Wietholt C; Urboniene D; Toth PT; Marsboom G; Zhang HJ; Haber I; Rehman J; Lopaschuk GD; Archer SL
    J Mol Med (Berl); 2010 Jan; 88(1):47-60. PubMed ID: 19949938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid Chromatography-Tandem Mass Spectrometry Method Revealed that Lung Cancer Cells Exhibited Distinct Metabolite Profiles upon the Treatment with Different Pyruvate Dehydrogenase Kinase Inhibitors.
    Zhang W; Hu X; Zhou W; Tam KY
    J Proteome Res; 2018 Sep; 17(9):3012-3021. PubMed ID: 30028142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of pyruvate dehydrogenase kinase-1 in gastric cancer as a potential therapeutic target.
    Hur H; Xuan Y; Kim YB; Lee G; Shim W; Yun J; Ham IH; Han SU
    Int J Oncol; 2013 Jan; 42(1):44-54. PubMed ID: 23135628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
    Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyruvate dehydrogenase kinase expression and metabolic changes following dichloroacetate exposure in anoxic human colorectal cancer cells.
    Ho N; Coomber BL
    Exp Cell Res; 2015 Feb; 331(1):73-81. PubMed ID: 25536473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel inhibitor of pyruvate dehydrogenase kinase stimulates myocardial carbohydrate oxidation in diet-induced obesity.
    Wu CY; Satapati S; Gui W; Wynn RM; Sharma G; Lou M; Qi X; Burgess SC; Malloy C; Khemtong C; Sherry AD; Chuang DT; Merritt ME
    J Biol Chem; 2018 Jun; 293(25):9604-9613. PubMed ID: 29739849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity in lung (18)FDG uptake in pulmonary arterial hypertension: potential of dynamic (18)FDG positron emission tomography with kinetic analysis as a bridging biomarker for pulmonary vascular remodeling targeted treatments.
    Zhao L; Ashek A; Wang L; Fang W; Dabral S; Dubois O; Cupitt J; Pullamsetti SS; Cotroneo E; Jones H; Tomasi G; Nguyen QD; Aboagye EO; El-Bahrawy MA; Barnes G; Howard LS; Gibbs JS; Gsell W; He JG; Wilkins MR
    Circulation; 2013 Sep; 128(11):1214-24. PubMed ID: 23900048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dichloroacetate, a metabolic modulator, prevents and reverses chronic hypoxic pulmonary hypertension in rats: role of increased expression and activity of voltage-gated potassium channels.
    Michelakis ED; McMurtry MS; Wu XC; Dyck JR; Moudgil R; Hopkins TA; Lopaschuk GD; Puttagunta L; Waite R; Archer SL
    Circulation; 2002 Jan; 105(2):244-50. PubMed ID: 11790708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dichloroacetate, an inhibitor of pyruvate dehydrogenase kinases, inhibits platelet aggregation and arterial thrombosis.
    Nayak MK; Dhanesha N; Doddapattar P; Rodriguez O; Sonkar VK; Dayal S; Chauhan AK
    Blood Adv; 2018 Aug; 2(15):2029-2038. PubMed ID: 30108111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effects of Sodium Dichloroacetate on Mitochondrial Dysfunction and Neuronal Death Following Hypoglycemia-Induced Injury.
    Kho AR; Choi BY; Lee SH; Hong DK; Jeong JH; Kang BS; Kang DH; Park KH; Park JB; Suh SW
    Cells; 2019 May; 8(5):. PubMed ID: 31052436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic Targeting of the Pyruvate Dehydrogenase Complex/Pyruvate Dehydrogenase Kinase (PDC/PDK) Axis in Cancer.
    Stacpoole PW
    J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Pyruvate Dehydrogenase Kinase by Dichloroacetate in Cancer and Skeletal Muscle Cells Is Isoform Specific and Partially Independent of HIF-1α.
    Škorja Milić N; Dolinar K; Miš K; Matkovič U; Bizjak M; Pavlin M; Podbregar M; Pirkmajer S
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial activation by inhibition of PDKII suppresses HIF1a signaling and angiogenesis in cancer.
    Sutendra G; Dromparis P; Kinnaird A; Stenson TH; Haromy A; Parker JM; McMurtry MS; Michelakis ED
    Oncogene; 2013 Mar; 32(13):1638-50. PubMed ID: 22614004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuin 3 deficiency is associated with inhibited mitochondrial function and pulmonary arterial hypertension in rodents and humans.
    Paulin R; Dromparis P; Sutendra G; Gurtu V; Zervopoulos S; Bowers L; Haromy A; Webster L; Provencher S; Bonnet S; Michelakis ED
    Cell Metab; 2014 Nov; 20(5):827-839. PubMed ID: 25284742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
    McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
    Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulating the Warburg effect on metabolic stress and myocardial fibrosis remodeling and atrial intracardiac waveform activity induced by atrial fibrillation.
    Hu HJ; Zhang C; Tang ZH; Qu SL; Jiang ZS
    Biochem Biophys Res Commun; 2019 Aug; 516(3):653-660. PubMed ID: 31242971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.